Sub menu

 
 

EVOCAIR MDI 125/25 fluticasone propionate 125 microgram/salmeterol (as xinafoate) 25 microgram inhalation - pressurised aerosol can - metered dose Cancelled under Section 30(1)(c) of the Act

Product name
EVOCAIR MDI 125/25 fluticasone propionate 125 microgram/salmeterol (as xinafoate) 25 microgram inhalation - pressurised aerosol can - metered dose
Sponsor
GlaxoSmithKline Australia Pty Ltd
ARTG
208198
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act

Help us improve the Therapeutic Goods Administration site